Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593004 | SCV000701553 | pathogenic | not provided | 2016-09-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000411266 | SCV003783259 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-10-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu164Serfs*47) in the SGCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). This variant is present in population databases (rs753650776, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SGCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 290625). For these reasons, this variant has been classified as Pathogenic. |
Counsyl | RCV000411266 | SCV000486984 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2016-09-21 | no assertion criteria provided | clinical testing |